Atlas Trials

A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer

Clinical trial NCT07349069 · RECRUITING

Trial details

NCT number
NCT07349069
Sponsor
Shandong Suncadia Medicine Co., Ltd.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2026-03-04
Primary completion
2030-12-01
Enrollment
5500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.